Skip to content
healthcare.dev

Ciclopirox

NDC 45802-141, Ciclopirox, solution, from Padagis Israel Pharmaceuticals Ltd.

Product NDC
45802-141
Status
Listed
Labeler
Padagis Israel Pharmaceuticals Ltd
Dosage form
SOLUTION
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077623
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/45802-141 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CICLOPIROX80 mg/mL

Pharmacologic classes

Decreased DNA Replication [PE]; Decreased Protein Synthesis [PE]; Decreased RNA Replication [PE]; Protein Synthesis Inhibitors [MoA]

Package NDCNDC-11Package
45802-141-67458020141671 BOTTLE, WITH APPLICATOR in 1 CARTON (45802-141-67) / 6.6 mL in 1 BOTTLE, WITH APPLICATOR

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/02f46b6e-b424-4210-83bf-e79618df4344
  • NADAC price for package 45802014167

    GET /v1/drugs/nadac/45802014167

Use it

Look up 45802-141 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/45802-141 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 45802-141. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.